E
Edwina V. Smith
Researcher at National Institute on Drug Abuse
Publications - 4
Citations - 547
Edwina V. Smith is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 4, co-authored 4 publications receiving 515 citations. Previous affiliations of Edwina V. Smith include National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Bupropion for the Treatment of Methamphetamine Dependence
Ahmed Elkashef,Richard A. Rawson,Ann L. Anderson,Shou-Hua Li,Tyson H. Holmes,Edwina V. Smith,Nora Chiang,Roberta Kahn,Frank Vocci,Walter Ling,Valerie Pearce,Michael McCann,Jan Campbell,Charles Gorodetzky,William Haning,Barry S. Carlton,Joseph Mawhinney,Dennis Weis +17 more
TL;DR: The data suggest that bupropion, in combination with behavioral group therapy, was effective for increasing the number of weeks of abstinence in participants with low-to-moderate methamphetamine dependence, mainly male patients, regardless of their comorbid condition.
Journal ArticleDOI
Modafinil for the treatment of cocaine dependence.
Ann L. Anderson,Malcolm S. Reid,Shou Hua Li,Tyson H. Holmes,Lynn Shemanski,April Slee,Edwina V. Smith,Roberta Kahn,Nora Chiang,Frank Vocci,Domenic A. Ciraulo,Charles A. Dackis,John D. Roache,Ihsan M. Salloum,Eugene Somoza,Harold C. Urschel,Ahmed Elkashef +16 more
TL;DR: Data suggest that modafinil, in combination with individual behavioral therapy, was effective for increasing cocaine non-use days in participants without co-morbid alcohol dependence, and in reducing cocaine craving.
Journal ArticleDOI
A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence
Bankole A. Johnson,Nassima Ait-Daoud,Ahmed Elkashef,Edwina V. Smith,Roberta Kahn,Francis Vocci,Shou-Hua Li,Daniel A. Bloch +7 more
TL;DR: The preliminary results do not support the utility of ondansetron, at the doses tested, as a treatment for methamphetamine dependence and should be viewed in light of the possibility that a less intensive cognitive behavioural therapy regimen might have yielded more positive results in this initial phase II trial.
Journal ArticleDOI
The NIDA Methamphetamine Clinical Trials Group: a strategy to increase clinical trials research capacity.
Ahmed Elkashef,Richard A. Rawson,Edwina V. Smith,Valerie Pearce,Frank Flammino,Jan Campbell,Roger Donovick,Charles Gorodetzky,William Haning,Joseph Mawhinney,Michael J. McCann,Dennis Weis,Lorie Williams,Walter Ling,Frank Vocci +14 more
TL;DR: Outcomes of the behavioral trial indicated that the MCTG recruited well; collected study data accurately and reliably; and created a vehicle that can assess promising pharmacotherapies for methamphetamine addiction treatment medications.